Skip to Main Content

Paper Details

A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma.
Scand J Gastroenterol
2
2023
AFP, DCP, FGF21, HCC, Patients, TXNRD1, alpha-fetoprotein, cirrhosis, decarboxy-prothrombin, fibroblast growth factor 21, hepatocellular carcinoma, liver cirrhosis, patients, thioredoxin reductase 1
Author NameAffiliation
Jochen M SchwenkKTH Royal Institute of Technology
Jochen M SchwenkKTH Royal Institute of Technology
  • 1 - 2

Datasets

Release 1.2